BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23763957)

  • 1. Determination of artemether and lumefantrine in anti-malarial fixed-dose combination tablets by microemulsion electrokinetic chromatography with short-end injection procedure.
    Amin NC; Fabre H; Blanchin MD; Montels J; Aké M
    Malar J; 2013 Jun; 12():202. PubMed ID: 23763957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary electrophoresis for the assay of fixed-dose combination tablets of artesunate and amodiaquine.
    Amin NC; Blanchin MD; Aké M; Montels J; Fabre H
    Malar J; 2012 May; 11():149. PubMed ID: 22554086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of artemether and lumefantrine in fixed dose combination tablets by HPLC with UV detection.
    César Ida C; Andrade Nogueira FH; Antônio Pianetti G
    J Pharm Biomed Anal; 2008 Nov; 48(3):951-4. PubMed ID: 18602241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products.
    Suleman S; Vandercruyssen K; Wynendaele E; D'Hondt M; Bracke N; Duchateau L; Burvenich C; Peremans K; De Spiegeleer B
    Malar J; 2013 Apr; 12():145. PubMed ID: 23631682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemether-Lumefantrine Concentrations in Tablets and Powders from Ghana Measured by a New High-Performance Liquid Chromatography Method.
    Debrah P; Nettey H; Miltersen KK; Ayeh-Kumi P; Brock B; Sarkodie JA; Akwo-Kretchy I; Owusu-Danso P; Adjei S; Petersen E; Hardlei TF
    Am J Trop Med Hyg; 2016 Jul; 95(1):158-63. PubMed ID: 27139437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-tandem mass spectrometry for the simultaneous quantitation of artemether and lumefantrine in human plasma: application for a pharmacokinetic study.
    César IC; Ribeiro JA; Teixeira Lde S; Bellorio KB; de Abreu FC; Moreira JM; Chellini PR; Pianetti GA
    J Pharm Biomed Anal; 2011 Jan; 54(1):114-20. PubMed ID: 20719459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Level A in vitro-in vivo correlation: Application to establish a dissolution test for artemether and lumefantrine tablets.
    Rivelli GG; Ricoy LBM; César IC; Fernandes C; Pianetti GA
    J Pharm Biomed Anal; 2018 Jun; 155():262-269. PubMed ID: 29674137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a generic liquid chromatographic method for the simultaneous determination of five commonly used antimalarial drugs: Application to pharmaceutical formulations and human plasma.
    Mannemala SS; Nagarajan JS
    J Sep Sci; 2015 May; 38(9):1521-8. PubMed ID: 25694118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical and chemical stability of expired fixed dose combination artemether-lumefantrine in uncontrolled tropical conditions.
    Bate R; Tren R; Hess K; Attaran A
    Malar J; 2009 Feb; 8():33. PubMed ID: 19243589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator's product.
    Minzi OM; Marealle IA; Shekalaghe S; Juma O; Ngaimisi E; Chemba M; Rutaihwa M; Abdulla S; Sasi P
    Malar J; 2013 May; 12():174. PubMed ID: 23718725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of artemisinin-based antimalarial drugs marketed in Nigeria.
    Izevbekhai O; Adeagbo B; Olagunju A; Bolaji O
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):90-96. PubMed ID: 28460126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
    Juma EA; Obonyo CO; Akhwale WS; Ogutu BR
    Malar J; 2008 Dec; 7():262. PubMed ID: 19102746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of folic acid in tablets by microemulsion electrokinetic chromatography.
    Aurora-Prado MS; Silva CA; Tavares MF; Altria KD
    J Chromatogr A; 2004 Oct; 1051(1-2):291-6. PubMed ID: 15532586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of lumefantrine and its metabolite in plasma by high performance liquid chromatography with ultraviolet detection.
    Khalil IF; Abildrup U; Alifrangis LH; Maiga D; Alifrangis M; Hoegberg L; Vestergaard LS; Persson OP; Nyagonde N; Lemnge MM; Theander TG; Bygbjerg IC
    J Pharm Biomed Anal; 2011 Jan; 54(1):168-72. PubMed ID: 20832961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HPLC, UV spectrophotometry and potentiometric titration methods for the determination of lumefantrine in pharmaceutical products.
    da Costa César I; Nogueira FH; Pianetti GA
    J Pharm Biomed Anal; 2008 Sep; 48(1):223-6. PubMed ID: 18571353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects.
    Abdulla S; Amuri B; Kabanywanyi AM; Ubben D; Reynolds C; Pascoe S; Fitoussi S; Yeh CM; Nuortti M; Séchaud R; Kaiser G; Lefèvre G
    Malar J; 2010 Sep; 9():253. PubMed ID: 20815879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper.
    Blessborn D; Römsing S; Annerberg A; Sundquist D; Björkman A; Lindegardh N; Bergqvist Y
    J Pharm Biomed Anal; 2007 Oct; 45(2):282-7. PubMed ID: 17719735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children.
    Abdulla S; Sagara I
    Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S7. PubMed ID: 19818174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire.
    Toure OA; Penali LK; Yapi JD; Ako BA; Toure W; Djerea K; Gomez GO; Makaila O
    Malar J; 2009 Jul; 8():148. PubMed ID: 19575797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of novel low-cost colorimetric, laser photometric, and visual fluorescent techniques for rapid identification of falsified medicines in resource-poor areas: application to artemether-lumefantrine.
    Green MD; Hostetler DM; Nettey H; Swamidoss I; Ranieri N; Newton PN
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):8-16. PubMed ID: 25897066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.